Aandeel NDAT NDATALYZE CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen nDatalyze Corp.

Aandelen

NDAT

CA63948H1055

Beurs gesloten - Canadian Securities Exchange
Andere beurzen
 21:48:27 08-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,14 CAD 0,00% Intraday-grafiek van nDatalyze Corp. -3,45% +3,70%
16/04 Ndatalyze Corp. Kondigt Executive Changes aan CI
16/04 NDatalyze Corp. (CNSX:NDAT) heeft de overname van Mindbalanced Inc. afgerond. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Closes its Previously-Announced Private Placement
NDatalyze Corp. announced that it has received CAD 0.20625 million in funding
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Announces a Private Placement and Provides an Update by its New President, Joshua Hill
NDatalyze Corp. announced that it expects to receive CAD 0.20625 million in funding
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) announces the closing of the Mindbalanced Inc. acquisition and the appointment of Joshua Hill as President.
Ndatalyze Corp. Announces Executive Changes
NDatalyze Corp. completed the acquisition of Mindbalanced Inc.
NDatalyze Corp. Announces a Formal Agreement with the Canadian Mental Health Association, Dr. Andrew Greenshaw, and Dr. Bo Cao.
Canadian Investment Regulatory Organization Trade Resumption - NDAT
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) announces an agreement to acquire Mindbalanced Inc.
Canadian Investment Regulatory Organization Trading Halt - NDAT
NDatalyze Corp. entered into an agreement to acquire Mindbalanced Inc. for CAD 2.2 million.
NDatalyze Corp. is Pleased to Review its Advanced Mental Condition Diagnostic System that Promises to Fundamentally Change Mental Health Diagnosis, Management and Treatment
NDatalyze Corp. Completes its DNA-Enhanced Records Gathering
NDatalyze Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Operational Update and Business Model Explanation
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) signs a formal Clinical Study agreement with Dr. Dale Stevens, Ph.D., Department of Psychology, Faculty of Health, York University.
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) announces a Letter of Intent with the Canadian Mental Health Association, Dr. Andrew Greenshaw, and Dr. Bo Cao.
Ndatalyze Corp. Extends the Letter of Intent to January 15, 2024
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Extends the Letter of Intent with Dr. Dale Stevens, Ph.D., Department of Psychology, Faculty of Health, York University
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers NDAT
  4. Nieuws nDatalyze Corp.
  5. Andere talen